CN105294699A - 巴瑞替尼的制备方法 - Google Patents
巴瑞替尼的制备方法 Download PDFInfo
- Publication number
- CN105294699A CN105294699A CN201510880931.XA CN201510880931A CN105294699A CN 105294699 A CN105294699 A CN 105294699A CN 201510880931 A CN201510880931 A CN 201510880931A CN 105294699 A CN105294699 A CN 105294699A
- Authority
- CN
- China
- Prior art keywords
- butyl formate
- azetidine
- reaction
- cyanomethylene
- pyrrolo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510880931.XA CN105294699B (zh) | 2015-12-04 | 2015-12-04 | 巴瑞替尼的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510880931.XA CN105294699B (zh) | 2015-12-04 | 2015-12-04 | 巴瑞替尼的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105294699A true CN105294699A (zh) | 2016-02-03 |
CN105294699B CN105294699B (zh) | 2019-06-11 |
Family
ID=55192607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510880931.XA Active CN105294699B (zh) | 2015-12-04 | 2015-12-04 | 巴瑞替尼的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105294699B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107176955A (zh) * | 2017-03-24 | 2017-09-19 | 南京优科制药有限公司 | 一种巴瑞替尼的制备方法 |
CN107915738A (zh) * | 2017-11-14 | 2018-04-17 | 厦门海乐景生化有限公司 | 用于合成巴瑞替尼的关键中间体2的制备方法 |
WO2018113801A1 (en) | 2016-12-21 | 2018-06-28 | Zentiva, K.S. | Crystalline forms of2-[1-ethylsulfonyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile with phosphoric acid and a method of their preparation |
CN108586465A (zh) * | 2017-12-13 | 2018-09-28 | 江苏中邦制药有限公司 | 一种巴瑞替尼的制备方法 |
CN108976233A (zh) * | 2017-06-02 | 2018-12-11 | 南京优科生物医药研究有限公司 | 巴瑞替尼的杂质及其制备、检测方法 |
CN110256441A (zh) * | 2019-06-24 | 2019-09-20 | 江苏君若医药有限公司 | 一种巴瑞克替尼的制备方法 |
US10766900B2 (en) | 2017-12-29 | 2020-09-08 | Formosa Laboratories, Inc. | Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof |
CN112225739A (zh) * | 2019-07-15 | 2021-01-15 | 宜昌东阳光制药有限公司 | 一种氮杂环丁烷化合物的制备方法 |
CN113582998A (zh) * | 2021-06-25 | 2021-11-02 | 江苏君若药业有限公司 | 4-(1H-吡唑-4-基)-7H-吡咯[2,3-d]嘧啶的制备 |
CN114007621A (zh) * | 2019-03-05 | 2022-02-01 | 因赛特公司 | 用于治疗慢性肺同种异体移植物功能障碍的jak1途径抑制剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102026999A (zh) * | 2008-03-11 | 2011-04-20 | 因塞特公司 | 作为jak抑制剂的氮杂环丁烷和环丁烷衍生物 |
CN102985424A (zh) * | 2010-04-14 | 2013-03-20 | 阵列生物制药公司 | 5,7-取代的-咪唑并[1,2-c]嘧啶 |
WO2014138168A1 (en) * | 2013-03-06 | 2014-09-12 | Incyte Corporation | Processes and intermediates for making a jak inhibitor |
-
2015
- 2015-12-04 CN CN201510880931.XA patent/CN105294699B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102026999A (zh) * | 2008-03-11 | 2011-04-20 | 因塞特公司 | 作为jak抑制剂的氮杂环丁烷和环丁烷衍生物 |
CN102985424A (zh) * | 2010-04-14 | 2013-03-20 | 阵列生物制药公司 | 5,7-取代的-咪唑并[1,2-c]嘧啶 |
WO2014138168A1 (en) * | 2013-03-06 | 2014-09-12 | Incyte Corporation | Processes and intermediates for making a jak inhibitor |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018113801A1 (en) | 2016-12-21 | 2018-06-28 | Zentiva, K.S. | Crystalline forms of2-[1-ethylsulfonyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile with phosphoric acid and a method of their preparation |
CN107176955B (zh) * | 2017-03-24 | 2019-04-09 | 南京优科制药有限公司 | 一种巴瑞替尼的制备方法 |
CN107176955A (zh) * | 2017-03-24 | 2017-09-19 | 南京优科制药有限公司 | 一种巴瑞替尼的制备方法 |
CN108976233A (zh) * | 2017-06-02 | 2018-12-11 | 南京优科生物医药研究有限公司 | 巴瑞替尼的杂质及其制备、检测方法 |
CN107915738A (zh) * | 2017-11-14 | 2018-04-17 | 厦门海乐景生化有限公司 | 用于合成巴瑞替尼的关键中间体2的制备方法 |
WO2019114258A1 (zh) * | 2017-12-13 | 2019-06-20 | 江苏中邦制药有限公司 | 一种巴瑞替尼的制备方法 |
CN108586465A (zh) * | 2017-12-13 | 2018-09-28 | 江苏中邦制药有限公司 | 一种巴瑞替尼的制备方法 |
US10766900B2 (en) | 2017-12-29 | 2020-09-08 | Formosa Laboratories, Inc. | Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof |
CN114007621A (zh) * | 2019-03-05 | 2022-02-01 | 因赛特公司 | 用于治疗慢性肺同种异体移植物功能障碍的jak1途径抑制剂 |
CN110256441A (zh) * | 2019-06-24 | 2019-09-20 | 江苏君若医药有限公司 | 一种巴瑞克替尼的制备方法 |
CN112225739A (zh) * | 2019-07-15 | 2021-01-15 | 宜昌东阳光制药有限公司 | 一种氮杂环丁烷化合物的制备方法 |
CN112225739B (zh) * | 2019-07-15 | 2024-04-26 | 宜昌东阳光制药有限公司 | 一种氮杂环丁烷化合物的制备方法 |
CN113582998A (zh) * | 2021-06-25 | 2021-11-02 | 江苏君若药业有限公司 | 4-(1H-吡唑-4-基)-7H-吡咯[2,3-d]嘧啶的制备 |
Also Published As
Publication number | Publication date |
---|---|
CN105294699B (zh) | 2019-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105294699A (zh) | 巴瑞替尼的制备方法 | |
CN107176955B (zh) | 一种巴瑞替尼的制备方法 | |
JP2012521420A (ja) | ボロン酸エステル化合物の製造方法 | |
CN102367260A (zh) | 2-氨基嘧啶-5-硼酸的合成方法 | |
TR201807444T4 (tr) | Amino asit bileşiklerini hazırlama prosesi. | |
CN105061405A (zh) | 非马沙坦钾盐三水合物的制备方法 | |
CN105017299A (zh) | 一种1,4-二烯基硼化合物的制备方法 | |
CN104211723A (zh) | 新型乙烯基硼化试剂的合成及应用 | |
CN103012268B (zh) | 一种伊伐布雷定制备方法 | |
CN104016969A (zh) | 用于Cu(Ⅰ)的配体的N2取代的1,2,3-三唑衍生物及其制备方法和应用 | |
CN103641674B (zh) | 一种二芳基砜的制备方法 | |
KR102136440B1 (ko) | 피리다지논 화합물 및 그의 제조 중간체의 제조 방법 | |
CN102791661B (zh) | 二氟环丙烷化合物的制造方法 | |
CN104945434B (zh) | (2﹣二取代膦苯基)-1-烷基-吲哚膦配体及其合成方法和应用 | |
CN113121432A (zh) | 一种带有导向基团的脂肪链烯烃的合成方法 | |
CN104001553B (zh) | N取代的1,2,3-三唑衍生物/Cu(I)复合催化剂及其合成与应用 | |
CN103113297B (zh) | 一种8-芳基-1-萘酰胺化合物及其制备方法 | |
CN108586280B (zh) | 合成n′-[(2s,3s)-2-(苄氧基)戊-3-基]甲酰肼的方法 | |
CN101891569B (zh) | α-芳基酮化合物的制备方法 | |
CN105669513A (zh) | 一种多取代3-炔基吡咯衍生物的制备方法 | |
CN107459533B (zh) | 一种苯并咪唑-吲哚骨架的膦配体及其制备方法和应用 | |
CN105102411A (zh) | 1,1,1,5,5,5-六氟乙酰丙酮的制造方法 | |
CN109096321B (zh) | 一种脱氧鸟苷类有机合成中间体的制备方法 | |
KR20170080190A (ko) | 1,5-쌍극자의 [5+3] 고리화 첨가 반응을 이용한 8원 헤테로 고리 화합물의 제조 방법 및 이에 의해 제조된 8원 헤테로 고리 화합물 | |
CN113354625B (zh) | 伏立康唑的合成工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: SHANGHAI XUNHE PHARMACEUTICAL TECHNOLOGY CO., LTD. Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201109 Address after: 570100 Haikou, Meilan District, Hainan Province Shunda Road, No. 6 Patentee after: HAINAN SELECTION PHARMACEUTICAL Co.,Ltd. Address before: 201199, Room 201, building 1B, seven Xin Xin Road, 1366, Shanghai, Minhang District Patentee before: Shanghai Xunhe Pharmaceutical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211112 Address after: 201199 Room 201, building 1b, No. 1366, Qishen Road, Minhang District, Shanghai Patentee after: Shanghai Xunhe Pharmaceutical Technology Co., Ltd Address before: 570100 No. 6, Shunda Road, Meilan District, Haikou City, Hainan Province Patentee before: Hainan sailike Pharmaceutical Co., Ltd |
|
TR01 | Transfer of patent right |